Qingdao Vland Biotech INC. (SHA:603739)
China · Delayed Price · Currency is CNY 11.57
+0.04 (0.35%)
Aug 4, 2026, 3:00 PM CST
SHA:603739 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,401 | 1,366 | 1,321 | 1,199 | 1,163 | 1,151 |
Revenue Growth | 4.23% | 3.44% | 10.16% | 3.07% | 1.07% | 19.85% |
Gross Profit Gross Profit Growth | 620.45 | 605.45 | 592.34 | 550.44 | 500.3 | 530.43 |
Operating Income Operating Income Growth | 87.79 | 86.45 | 114.44 | 103.12 | 79.68 | 129.74 |
Net Income Net Income Growth | 78.1 | 69.81 | 62.64 | 80.71 | 69.84 | 132.57 |
Earnings Per Share EPS Growth | 0.31 | 0.28 | 0.25 | 0.32 | 0.27 | 0.54 |
EPS Growth | 27.92% | 12.00% | -21.88% | 18.52% | -50.00% | 12.50% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Movable Insurance Division Movable Insurance Division Growth | 495.69 |
Biology Division Biology Division Growth | 954.44 |
Inter-Segment Elimination Inter-Segment Elimination Growth | -84.01 |
Total Total Growth | 1,366 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 497.38 | 469.02 | 448.07 | 531.64 | 425.89 | 482.27 |
Total Debt Total Debt Growth | 696.51 | 678.78 | 635.62 | 723.92 | 523.22 | 235.93 |
Net Cash (Debt) Net Cash Growth | -199.13 | -209.76 | -187.55 | -192.27 | -97.33 | 246.34 |
Net Cash Growth | - | - | - | - | - | -11.88% |
Net Cash Per Share Net Cash Per Share Growth | -0.79 | -0.84 | -0.75 | -0.76 | -0.38 | 1.00 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 124.59 | 113.95 | 195.41 | 153.59 | 95.31 | 89.51 |
Capital Expenditures CapEx Growth | -53.44 | -80.01 | -104.72 | -215.64 | -342.02 | -493.58 |
Free Cash Flow Free Cash Flow Growth | 71.15 | 33.94 | 90.69 | -62.05 | -246.72 | -404.06 |
Free Cash Flow Growth | -19.04% | -62.58% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.29% | 44.32% | 44.85% | 45.91% | 43.01% | 46.09% |
Operating Margin | 6.27% | 6.33% | 8.66% | 8.60% | 6.85% | 11.27% |
Pretax Margin | 9.39% | 9.06% | 9.35% | 10.22% | 8.79% | 14.89% |
Profit Margin | 5.58% | 5.11% | 4.74% | 6.73% | 6.00% | 11.52% |
FCF Margin | 5.08% | 2.48% | 6.87% | -5.18% | -21.21% | -35.11% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.100 | 0.100 | 0.100 | 0.160 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | -37.50% | 11.97% |
Dividend Yield | 0.87% | 0.71% | 0.85% | 0.67% | 0.77% | 0.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.52 | 51.29 | 48.44 | 47.72 | 48.50 | 35.37 |
Forward PE | 33.06 | 39.58 | 30.10 | 29.41 | 29.50 | 20.11 |
P/FCF Ratio | 41.14 | 105.50 | 33.45 | - | - | - |
PS Ratio | 2.09 | 2.62 | 2.30 | 3.21 | 2.91 | 4.07 |